EUVIMEDEUVIMED entdecken
Crossref

MHRA regulatory considerations for the quality of mRNA products

Ka-Wai Wan, Francis Galaway

Nucleic Acid Insights · 2024

DOI: 10.18609/nai.2024.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, 2024. Verfasst von Ka-Wai Wan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wan, K., & Galaway, F. (2024). MHRA regulatory considerations for the quality of mRNA products. Nucleic Acid Insights. https://doi.org/10.18609/nai.2024.020

Vancouver

Wan K, Galaway F. MHRA regulatory considerations for the quality of mRNA products. Nucleic Acid Insights. 2024. doi:10.18609/nai.2024.020

BibTeX
@article{Wan2024,
  author = {Wan, Ka-Wai and Galaway, Francis},
  title = {MHRA regulatory considerations for the quality of mRNA products},
  journal = {Nucleic Acid Insights},
  year = {2024},
  doi = {10.18609/nai.2024.020}
}
Kostenlos starten →